European Commission clears Pfizer acquisition of Pharmacia with proviso

Published: 2003-03-05 06:57:00

Updated: 2003-03-05 06:57:00

The Financial Times of the U.K. reported that Pfizer Inc's acquisition of Pharmacia Corp. for $54 billion in stock was approved by the European Commission on February 27 under the conditions that some launched items and compounds in development by the two companies should be divested prior to EC'...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK